| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 2919973 | Heart, Lung and Circulation | 2012 | 7 Pages |
Abstract
The question whether to anticoagulate patients with cardiomyopathy or not is over 50 years old. Multiple clinical trials have demonstrated the superior therapeutic effect of warfarin compared with placebo in the prevention of thromboembolic events amongst patients with nonvalvular atrial fibrillation. The purpose of our work is to review literature about the role of anticoagulation in the main cardiomyopathies.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Enrico Vizzardi, Ivano Bonadei, Francesca Del Magro, Silvia Bugatti, Antonio D’Aloia, Antonio Curnis, Livio Dei Cas,